Reducing residual cardiovascular risk in Europe: Therapeutic implications of European medicines agency approval of icosapent ethyl/eicosapentaenoic acid
出版年份 2022 全文链接
标题
Reducing residual cardiovascular risk in Europe: Therapeutic implications of European medicines agency approval of icosapent ethyl/eicosapentaenoic acid
作者
关键词
-
出版物
PHARMACOLOGY & THERAPEUTICS
Volume 237, Issue -, Pages 108172
出版商
Elsevier BV
发表日期
2022-03-16
DOI
10.1016/j.pharmthera.2022.108172
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Icosapent Ethyl for Primary Versus Secondary Prevention of Major Adverse Cardiovascular Events in Hypertriglyceridemia-Value for Money Analysis
- (2021) Ronen Arbel et al. AMERICAN JOURNAL OF MEDICINE
- Triglycerides and risk of atherosclerotic cardiovascular disease: An update
- (2021) Michel Farnier et al. Archives of Cardiovascular Diseases
- Practical guidance for combination lipid-modifying therapy in high- and very-high-risk patients: A statement from a European Atherosclerosis Society Task Force
- (2021) Maurizio Averna et al. ATHEROSCLEROSIS
- Cardiovascular effects of omega-3 fatty acids: Hope or hype?
- (2021) Sang-Ho Jo et al. ATHEROSCLEROSIS
- The changing landscape of atherosclerosis
- (2021) Peter Libby NATURE
- EPA’s pleiotropic mechanisms of action: a narrative review
- (2021) John R. Nelson et al. POSTGRADUATE MEDICINE
- 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
- (2021) Frank L J Visseren et al. EUROPEAN HEART JOURNAL
- A possible explanation for the contrasting results of REDUCE-IT vs. STRENGTH: cohort study mimicking trial designs
- (2021) Takahito Doi et al. EUROPEAN HEART JOURNAL
- Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies—a consensus statement from the European Atherosclerosis Society
- (2021) Henry N Ginsberg et al. EUROPEAN HEART JOURNAL
- Triglycerides and Residual Atherosclerotic Risk
- (2021) Sergio Raposeiras-Roubin et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- 2021 ACC Expert Consensus Decision Pathway on the Management of ASCVD Risk Reduction in Patients With Persistent Hypertriglyceridemia
- (2021) Salim S. Virani et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The reduction in cardiovascular risk in REDUCE-IT is due to eicosapentaenoic acid in icosapent ethyl
- (2021) Ph Gabriel Steg et al. EUROPEAN HEART JOURNAL
- Are dietary fish oil supplements appropriate for dyslipidemia management? A review of the evidence
- (2020) Samuel C.R. Sherratt et al. CURRENT OPINION IN LIPIDOLOGY
- Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel
- (2020) Jan Borén et al. EUROPEAN HEART JOURNAL
- The cost-effectiveness of icosapent ethyl in combination with statin therapy compared with statin alone for cardiovascular risk reduction
- (2020) Zanfina Ademi et al. European Journal of Preventive Cardiology
- Emerging Mechanisms of Cardiovascular Protection for the Omega-3 Fatty Acid Eicosapentaenoic Acid
- (2020) R. Preston Mason et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Triglycerides and remnant cholesterol associated with risk of aortic valve stenosis: Mendelian randomization in the Copenhagen General Population Study
- (2020) Morten Kaltoft et al. EUROPEAN HEART JOURNAL
- Improving Risk Assessment in the European Food Safety Authority: Lessons From the European Medicines Agency
- (2020) Sevasti Chatzopoulou et al. Frontiers in Plant Science
- Causes and Consequences of Hypertriglyceridemia
- (2020) Chris J. Packard et al. Frontiers in Endocrinology
- Applicability of the REDUCE‐IT trial to the FAST‐MI registry. Are the results of randomized trials relevant in routine clinical practice?
- (2020) Jean Ferrières et al. CLINICAL CARDIOLOGY
- Remnant lipoproteins
- (2020) Carlos A. Aguilar Salinas et al. CURRENT OPINION IN LIPIDOLOGY
- Effects of Fatty Acid Therapy in Addition to Strong Statin on Coronary Plaques in Acute Coronary Syndrome: An Optical Coherence Tomography Study
- (2020) Yoko Kita et al. Journal of the American Heart Association
- The Effectiveness and Value of Rivaroxaban and Icosapent Ethyl as Additive Therapies for Cardiovascular Disease
- (2020) Patricia G. Synnott et al. Journal of Managed Care & Specialty Pharmacy
- Omega n-3 Supplementation: Exploring the Cardiovascular Benefits Beyond Lipoprotein Reduction
- (2020) Alberto Zambon et al. Current Atherosclerosis Reports
- Effect of icosapent ethyl on progression of coronary atherosclerosis in patients with elevated triglycerides on statin therapy: final results of the EVAPORATE trial
- (2020) Matthew J Budoff et al. EUROPEAN HEART JOURNAL
- Reduction in Revascularization With Icosapent Ethyl
- (2020) Benjamin E. Peterson et al. CIRCULATION
- Effects of n-3 Fatty Acid Supplements in Elderly Patients after Myocardial Infarction: A Randomized Controlled Trial
- (2020) Are Annesønn Kalstad et al. CIRCULATION
- Inflammation in Atherosclerosis—No Longer a Theory
- (2020) Peter Libby CLINICAL CHEMISTRY
- Effects of Omega-3 Fatty Acids on Major Adverse Cardiovascular Events
- (2020) Garima Sharma et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk
- (2020) Stephen J. Nicholls et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019
- (2020) Gregory A. Roth et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Dose- and time-dependent increase in circulating anti-inflammatory and pro-resolving lipid mediators following eicosapentaenoic acid supplementation in patients with major depressive disorder and chronic inflammation
- (2020) Stefania Lamon-Fava et al. PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS
- PCV55 Cost-Effectiveness of Icosapent Ethyl (IPE) for the Reduction of the Risk of Ischemic Cardiovascular Events in Canada.
- (2020) J. Lachaine et al. VALUE IN HEALTH
- Eicosapentaenoic Acid Improves Hepatic Metabolism and Reduces Inflammation Independent of Obesity in High-Fat-Fed Mice and in HepG2 Cells
- (2019) Kembra Albracht-Schulte et al. Nutrients
- Effects of Icosapent Ethyl on Total Ischemic Events: From REDUCE-IT
- (2019) Deepak L. Bhatt et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Generalizability of the REDUCE-IT Trial in Patients With Stable Coronary Artery Disease
- (2019) Fabien Picard et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Association of Triglyceride-Lowering LPL Variants and LDL-C–Lowering LDLR Variants With Risk of Coronary Heart Disease
- (2019) Brian A. Ference et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Incidence, factors, and clinical significance of cholesterol crystals in coronary plaque: An optical coherence tomography study
- (2019) Kazuhiro Fujiyoshi et al. ATHEROSCLEROSIS
- Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC-EORP EUROASPIRE V survey in 27 countries
- (2019) Guy De Backer et al. ATHEROSCLEROSIS
- The cost-effectiveness of omega-3 polyunsaturated fatty acids – The Australian healthcare perspective
- (2019) Lan Gao et al. European Journal of Internal Medicine
- The Economic Burden of Hypertriglyceridemia Among US Adults With Diabetes or Atherosclerotic Cardiovascular Disease on Statin Therapy
- (2019) Brian C. Case et al. Journal of Clinical Lipidology
- 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk
- (2019) François Mach et al. EUROPEAN HEART JOURNAL
- Reduction in First and Total Ischemic Events With Icosapent Ethyl Across Baseline Triglyceride Tertiles
- (2019) Deepak L. Bhatt et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Association of Elevated Triglycerides With Increased Cardiovascular Risk and Direct Costs in Statin-Treated Patients
- (2019) Peter P. Toth et al. MAYO CLINIC PROCEEDINGS
- Rare dyslipidaemias, from phenotype to genotype to management: a European Atherosclerosis Society task force consensus statement
- (2019) Robert A Hegele et al. Lancet Diabetes & Endocrinology
- Clinical review on triglycerides
- (2019) Ulrich Laufs et al. EUROPEAN HEART JOURNAL
- Body mass index, triglycerides and risk of acute pancreatitis: A population-based study of 118,000 individuals
- (2019) Signe E J Hansen et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Understanding why REDUCE-IT was positive – Mechanistic overview of eicosapentaenoic acid
- (2019) William S. Harris PROGRESS IN CARDIOVASCULAR DISEASES
- Quantifying atherogenic lipoproteins for lipid-lowering strategies: consensus-based recommendations from EAS and EFLM
- (2019) Michel R. Langlois et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- European Society of Cardiology: Cardiovascular Disease Statistics 2019
- (2019) Adam Timmis et al. EUROPEAN HEART JOURNAL
- Eicosapentaenoic acid improves endothelial function and nitric oxide bioavailability in a manner that is enhanced in combination with a statin
- (2018) R. Preston Mason et al. BIOMEDICINE & PHARMACOTHERAPY
- Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators
- (2018) Charles N. Serhan et al. JOURNAL OF CLINICAL INVESTIGATION
- Unmet Need for Adjunctive Dyslipidemia Therapy in Hypertriglyceridemia Management
- (2018) Om P. Ganda et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Remnant-Like Particle Cholesterol, Low-Density Lipoprotein Triglycerides, and Incident Cardiovascular Disease
- (2018) Anum Saeed et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Effects of n−3 Fatty Acid Supplements in Diabetes Mellitus
- (2018) NEW ENGLAND JOURNAL OF MEDICINE
- Rationale and design of the Pemafibrate to Reduce Cardiovascular Outcomes by Reducing Triglycerides in Patients with Diabetes (PROMINENT) study
- (2018) Aruna D. Pradhan et al. AMERICAN HEART JOURNAL
- Omega-3 fatty acids and nonalcoholic fatty liver disease in adults and children
- (2018) Melinda H. Spooner et al. CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE
- Marine n−3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer
- (2018) JoAnn E. Manson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
- (2018) Deepak L. Bhatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
- (2017) Brian A. Ference et al. EUROPEAN HEART JOURNAL
- Monocyte-Macrophages and T Cells in Atherosclerosis
- (2017) Ira Tabas et al. IMMUNITY
- A randomized controlled trial of eicosapentaenoic acid in patients with coronary heart disease on statins
- (2017) Tetsu Watanabe et al. Journal of Cardiology
- Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
- (2017) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Triglycerides and Triglyceride-Rich Lipoproteins in the Causal Pathway of Cardiovascular Disease
- (2016) Matthew Budoff AMERICAN JOURNAL OF CARDIOLOGY
- Icosapent ethyl (eicosapentaenoic acid ethyl ester): Effects on remnant-like particle cholesterol from the MARINE and ANCHOR studies
- (2016) Christie M. Ballantyne et al. ATHEROSCLEROSIS
- Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease
- (2016) Børge G. Nordestgaard CIRCULATION RESEARCH
- DHA- and EPA-derived resolvins, protectins, and maresins in airway inflammation
- (2016) Melody G. Duvall et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Cytochrome P450 epoxygenase pathway of polyunsaturated fatty acid metabolism
- (2015) Arthur A. Spector et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Prevalence of M4 macrophages within human coronary atherosclerotic plaques is associated with features of plaque instability
- (2015) Christian Erbel et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Changes in transcriptome of macrophages in atherosclerosis
- (2015) Dimitry A. Chistiakov et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Fasting Triglycerides Predict Recurrent Ischemic Events in Patients With Acute Coronary Syndrome Treated With Statins
- (2015) Gregory G. Schwartz et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Fish oil supplements in New Zealand are highly oxidised and do not meet label content of n-3 PUFA
- (2015) Benjamin B. Albert et al. Scientific Reports
- Stabilizing effect of combined eicosapentaenoic acid and statin therapy on coronary thin-cap fibroatheroma
- (2014) Ryo Nishio et al. ATHEROSCLEROSIS
- Plasma triglycerides predict ten-years all-cause mortality in outpatients with type 2 diabetes mellitus: a longitudinal observational study
- (2014) Maria-Agata Miselli et al. Cardiovascular Diabetology
- Triglycerides and cardiovascular disease
- (2014) Børge G Nordestgaard et al. LANCET
- An International Atherosclerosis Society Position Paper: Global recommendations for the management of dyslipidemia
- (2013) Scott M. Grundy et al. ATHEROSCLEROSIS
- An International Atherosclerosis Society Position Paper: Global recommendations for the management of dyslipidemia-Full report
- (2013) Scott M. Grundy et al. Journal of Clinical Lipidology
- n–3 Fatty Acids in Patients with Multiple Cardiovascular Risk Factors
- (2013) NEW ENGLAND JOURNAL OF MEDICINE
- The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management
- (2013) Robert A Hegele et al. Lancet Diabetes & Endocrinology
- Efficacy and Safety of Eicosapentaenoic Acid Ethyl Ester (AMR101) Therapy in Statin-Treated Patients With Persistent High Triglycerides (from the ANCHOR Study)
- (2012) Christie M. Ballantyne et al. AMERICAN JOURNAL OF CARDIOLOGY
- Genetically elevated non-fasting triglycerides and calculated remnant cholesterol as causal risk factors for myocardial infarction
- (2012) Anders Berg Jørgensen et al. EUROPEAN HEART JOURNAL
- French Registry on Acute ST-elevation and non ST-elevation Myocardial Infarction 2010. FAST-MI 2010
- (2012) Michel Hanssen et al. HEART
- Icosapent ethyl, a pure EPA omega-3 fatty acid: Effects on lipoprotein particle concentration and size in patients with very high triglyceride levels (the MARINE study)
- (2012) Harold E. Bays et al. Journal of Clinical Lipidology
- Macrophage Differentiation and Function in Atherosclerosis: Opportunities for Therapeutic Intervention?
- (2012) Howell J. Williams et al. Journal of Innate Immunity
- Remnant Cholesterol as a Causal Risk Factor for Ischemic Heart Disease
- (2012) Anette Varbo et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- n–3 Fatty Acids and Cardiovascular Outcomes in Patients with Dysglycemia
- (2012) NEW ENGLAND JOURNAL OF MEDICINE
- Hypertriglyceridemia secondary to obesity and diabetes
- (2011) Savitha Subramanian et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Relationship Between Coronary Plaque Vulnerability and Serum n-3/n-6 Polyunsaturated Fatty Acid Ratio
- (2011) Toshikazu Kashiyama et al. CIRCULATION JOURNAL
- Residual Cardiovascular Risk Despite Optimal LDL Cholesterol Reduction with Statins: The Evidence, Etiology, and Therapeutic Challenges
- (2011) Uchechukwu K. Sampson et al. Current Atherosclerosis Reports
- Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management
- (2011) M. John Chapman et al. EUROPEAN HEART JOURNAL
- Add-on Therapy of EPA Reduces Oxidative Stress and Inhibits the Progression of Aortic Stiffness in Patients with Coronary Artery Disease and Statin Therapy: A Randomized Controlled Study
- (2011) Akira Takaki et al. Journal of Atherosclerosis and Thrombosis
- OMEGA, a Randomized, Placebo-Controlled Trial to Test the Effect of Highly Purified Omega-3 Fatty Acids on Top of Modern Guideline-Adjusted Therapy After Myocardial Infarction
- (2010) Bernhard Rauch et al. CIRCULATION
- n–3 Fatty Acids and Cardiovascular Events after Myocardial Infarction
- (2010) Daan Kromhout et al. NEW ENGLAND JOURNAL OF MEDICINE
- Impact of Triglyceride Levels Beyond Low-Density Lipoprotein Cholesterol After Acute Coronary Syndrome in the PROVE IT-TIMI 22 Trial
- (2008) Michael Miller et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now